drugset / Trial / NCT00460577

Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction

NCT00460577

Phase 4 Completed 60 enrolled Novartis
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To determine efficacy and tolerability of inhaled Formoterol vs nebulized Ipatropioum Bromide plus Fenoterol in cumulative sequential doses in asthmatic children (5-\<12 years) with acute bronchial obstruction attending emergency services

Timeline

Start
2007-03
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenoterol Unknown 0.5 ug Inhaled
Comparator Formoterol Other / unclassified 12 ug Inhaled
Comparator Ipratropium Small molecule 0.25 mg Inhaled

Indications